SAN FRANCISCO, January 23, 2026 – Delaying treatment for HIV can significantly increase the risk of dementia later in life, according to new research. The study highlights the importance of early antiretroviral therapy (ART) in preserving cognitive health for individuals living with HIV.
The Link Between Delayed HIV Treatment and Dementia
Table of Contents
New findings reveal a connection between starting ART with a low CD4 count and a higher likelihood of dementia diagnosis years down the line.
- Patients who began ART when their CD4 count was low faced a greater risk of dementia.
- The research underscores the long-term neurological implications of HIV infection.
- Early initiation of ART may help protect against age-related cognitive decline in people with HIV.
The study, published in the journal Open Forum Infectious Diseases, found that individuals with HIV who initiated ART after experiencing a significantly weakened immune system – indicated by a low CD4 count – were more prone to developing dementia in subsequent years. this suggests that the duration of immune dysfunction before treatment plays a crucial role in long-term brain health.
What factors contribute to dementia risk in people with HIV? Dementia risk is a complex interplay of lifestyle, genetics, and chronic disease. Understanding the specific factors that impact cognitive function in individuals with HIV is essential for developing effective prevention strategies.
“The finding that delayed ART can raise the risk of age-related dementia is eye-opening,” said Craig E. Hou, MD, a neurologist with The Permanente Medical Group. “Dementia risk involves multiple factors, from lifestyle to genetics, and can be even more complex among people with chronic disease. having more evidence about what contributes to our patients’ cognitive issues will help us better understand and prevent dementias in the future.”
Understanding CD4 Counts and ART
CD4 cells, a type of white blood cell, are critical for immune function. A low CD4 count indicates a weakened immune system,making individuals more vulnerable to opportunistic infections and other health complications. Antiretroviral therapy (ART) works by suppressing the replication of HIV, allowing the immune system to recover and CD4 counts to increase.
Implications for Patient Care
These findings emphasize the importance of early HIV diagnosis and prompt initiation of ART. Healthcare providers should prioritize testing and treatment to minimize the period of immune dysfunction and potentially reduce the long-term risk of dementia. Further research is needed to fully elucidate the mechanisms underlying this association.
Why did this happen? Researchers discovered a correlation between delayed ART initiation and increased dementia risk. The longer HIV went untreated, and the lower the CD4 count dropped, the higher the likelihood of developing dementia later in life.
Who was affected? The study focused on individuals living with HIV. Specifically, those who began ART with already weakened immune systems (low CD4 counts) were most vulnerable to the increased dementia risk.
What was the outcome? The research demonstrated a clear link between delayed treatment and cognitive decline. This finding underscores the critical need for early HIV diagnosis and immediate ART initiation to protect long-term brain health.
How did it end? The study concluded with a call for further research to understand the underlying mechanisms of this association. It also emphasized the importance of prioritizing early HIV testing and treatment as a preventative measure against dementia.
